Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1983 1
1988 2
1989 2
1991 2
1992 8
1993 2
1994 1
1995 2
1996 2
1998 4
1999 2
2000 3
2001 4
2002 4
2003 6
2004 3
2005 5
2006 12
2007 12
2008 11
2009 14
2010 14
2011 10
2012 16
2013 9
2014 13
2015 13
2016 20
2017 17
2018 14
2019 19
2020 18
2021 12
2022 15
2023 11
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

273 results

Results by year

Filters applied: . Clear all
Page 1
Acromegaly: pathogenesis, diagnosis, and management.
Fleseriu M, Langlois F, Lim DST, Varlamov EV, Melmed S. Fleseriu M, et al. Lancet Diabetes Endocrinol. 2022 Nov;10(11):804-826. doi: 10.1016/S2213-8587(22)00244-3. Epub 2022 Oct 6. Lancet Diabetes Endocrinol. 2022. PMID: 36209758 Review.
Growth hormone-secreting pituitary adenomas that cause acromegaly arise as monoclonal expansions of differentiated somatotroph cells and are usually sporadic. They are almost invariably benign, yet they can be locally invasive and show progressi
Growth hormone-secreting pituitary adenomas that cause acromegaly arise as monoclonal expansions of differentiat
Diagnosis and Treatment of Acromegaly: An Update.
Ershadinia N, Tritos NA. Ershadinia N, et al. Mayo Clin Proc. 2022 Feb;97(2):333-346. doi: 10.1016/j.mayocp.2021.11.007. Mayo Clin Proc. 2022. PMID: 35120696 Review.
Acromegaly is typically caused by a growth hormone-secreting pituitary adenoma, driving excess secretion of insulin-like growth factor 1. ...Pituitary magnetic resonance imaging is advised in patients with acromegaly to identify an …
Acromegaly is typically caused by a growth hormone-secreting pituitary adenoma, driving excess secretion …
Diagnosis and Treatment of Pituitary Adenomas: A Review.
Molitch ME. Molitch ME. JAMA. 2017 Feb 7;317(5):516-524. doi: 10.1001/jama.2016.19699. JAMA. 2017. PMID: 28170483 Review.
Prolactinomas account for 32% to 66% of adenomas and present with amenorrhea, loss of libido, galactorrhea, and infertility in women and loss of libido, erectile dysfunction, and infertility in men; they are generally treated with the dopamine agonists cabergoline and bromocripti …
Prolactinomas account for 32% to 66% of adenomas and present with amenorrhea, loss of libido, galactorrhea, and infertility in women and los …
Somatostatin Analogs in Clinical Practice: a Review.
Gomes-Porras M, Cárdenas-Salas J, Álvarez-Escolá C. Gomes-Porras M, et al. Int J Mol Sci. 2020 Feb 29;21(5):1682. doi: 10.3390/ijms21051682. Int J Mol Sci. 2020. PMID: 32121432 Free PMC article. Review.
Acromegaly pathogenesis and treatment.
Melmed S. Melmed S. J Clin Invest. 2009 Nov;119(11):3189-202. doi: 10.1172/JCI39375. Epub 2009 Nov 2. J Clin Invest. 2009. PMID: 19884662 Free PMC article. Review.
Dysregulated growth hormone (GH) hypersecretion is usually caused by a GH-secreting pituitary adenoma and leads to acromegaly - a disorder of disproportionate skeletal, tissue, and organ growth. ...Somatostatin receptor (SSTR) ligands inhibit GH releas …
Dysregulated growth hormone (GH) hypersecretion is usually caused by a GH-secreting pituitary adenoma and leads to acro …
Carney Complex.
Kamilaris CDC, Faucz FR, Voutetakis A, Stratakis CA. Kamilaris CDC, et al. Exp Clin Endocrinol Diabetes. 2019 Feb;127(2-03):156-164. doi: 10.1055/a-0753-4943. Epub 2018 Nov 14. Exp Clin Endocrinol Diabetes. 2019. PMID: 30428497 Free article. Review.
Endocrine manifestations include primary pigmented nodular adrenocortical disease, that may cause Cushing syndrome, growth-hormone secreting pituitary adenoma or pituitary somatotropic hyperplasia which can result in acromegaly, as well a …
Endocrine manifestations include primary pigmented nodular adrenocortical disease, that may cause Cushing syndrome, growth-hormone
Overview of the 2017 WHO Classification of Pituitary Tumors.
Mete O, Lopes MB. Mete O, et al. Endocr Pathol. 2017 Sep;28(3):228-243. doi: 10.1007/s12022-017-9498-z. Endocr Pathol. 2017. PMID: 28766057 Review.
This new classification does not require a routine ultrastructural examination of these tumors. The new definition of the Null cell adenoma requires the demonstration of immunonegativity for pituitary transcription factors and adenohypophyseal hormones Moreover, the …
This new classification does not require a routine ultrastructural examination of these tumors. The new definition of the Null cell adeno
Pituitary tumour types in dogs and cats.
Sanders K, Galac S, Meij BP. Sanders K, et al. Vet J. 2021 Apr;270:105623. doi: 10.1016/j.tvjl.2021.105623. Epub 2021 Jan 25. Vet J. 2021. PMID: 33641809 Free article. Review.
In dogs, the most common pituitary tumour type is the corticotroph adenoma, which can cause pituitary-dependent hypercortisolism. In cats, the most common pituitary tumour is the somatotroph adenoma, which can cause hypersomatotropism, an …
In dogs, the most common pituitary tumour type is the corticotroph adenoma, which can cause pituitary-dependent hyperco …
Pituitary-Tumor Endocrinopathies.
Melmed S. Melmed S. N Engl J Med. 2020 Mar 5;382(10):937-950. doi: 10.1056/NEJMra1810772. N Engl J Med. 2020. PMID: 32130815 Review. No abstract available.
The 2017 WHO classification of pituitary adenoma: overview and comments.
Inoshita N, Nishioka H. Inoshita N, et al. Brain Tumor Pathol. 2018 Apr;35(2):51-56. doi: 10.1007/s10014-018-0314-3. Epub 2018 Apr 23. Brain Tumor Pathol. 2018. PMID: 29687298 Review.
The other change is the introduction of more precise cell lineage-based classification of pituitary adenoma that is defined based on lineage-specific transcription factors and hormones produced. ...In this review, we summarized these changes in the WHO classificatio …
The other change is the introduction of more precise cell lineage-based classification of pituitary adenoma that is defined ba …
273 results